Strategic Investment Advisors Eli Lilly & CO Transaction History
Strategic Investment Advisors
- $777 Million
- Q1 2024
A detailed history of Strategic Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Investment Advisors holds 2,513 shares of LLY stock, worth $2.38 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
2,513
Previous 2,580
2.6%
Holding current value
$2.38 Million
Previous $1.5 Million
30.07%
% of portfolio
0.25%
Previous 0.22%
Shares
16 transactions
Others Institutions Holding LLY
# of Institutions
3,729Shares Held
738MCall Options Held
9.09MPut Options Held
7.22M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$93.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$69 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$61.9 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$48.8 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$32.5 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $901B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...